Drug-Induced Impulse Control Disorders: A Review

被引:12
作者
Atmaca, Murad [1 ]
机构
[1] Firat Univ, Sch Med, Dept Psychiat, Elazig, Turkey
来源
CURRENT CLINICAL PHARMACOLOGY | 2014年 / 9卷 / 01期
关键词
Impulse control disorders; dopaminergic agents; pathological gambling;
D O I
10.2174/1574884708666131111202954
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The essential characteristic of impulse disorders is the failure to resist an impulse, drive or temptation to perform an act that is harmful to the person or to others. Clearly, impulse control disorders can occur without an induction of any drugs, and they may lead to very problematic situations that affect the adjustment of the patient and need to be treated immediately. However, the subject of the present review is impulsivity induced by a variety of drugs. In this context, the most frequently established agents are dopaminergic agonists that may affect the mesolimbic dopaminergic pathway, such as cocaine and methamphetamine. In Parkinson's disease, the triggering effect of levodopa on pounding has been known since the first description of the condition by Friedman. In this paper, we reviewed the role of a variety of psychopharmacological agents, including dopaminergic ones on the occurrence of impulse control disorders, by searching the PubMed database for relevant articles published in the period between 1980 and 2012 August in detail.
引用
收藏
页码:70 / 74
页数:5
相关论文
共 49 条
  • [1] American Psychiatric Association (APA), 2000, AM PSYCH ASS APA DIA
  • [2] Behavioural Adverse Effects of Dopaminergic Treatments in Parkinson's Disease Incidence, Neurobiological Basis, Management and Prevention
    Antonini, Angelo
    Cilia, Roberto
    [J]. DRUG SAFETY, 2009, 32 (06) : 475 - 488
  • [3] A systematic review of modafinil: Potential clinical uses and mechanisms of action
    Ballon, Jacob S.
    Feifel, David
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (04) : 554 - 566
  • [4] Blanco C, 1996, AM J PSYCHIAT, V153, P119
  • [5] Blum K, 1996, AM SCI, V84, P132
  • [6] Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinsons patients
    Bodi, Nikoletta
    Keri, Szabolcs
    Nagy, Helga
    Moustafa, Ahmed
    Myers, Catherine E.
    Daw, Nathaniel
    Dibo, Gyoergy
    Takats, Annamaria
    Bereczki, Daniel
    Gluck, Mark A.
    [J]. BRAIN, 2009, 132 : 2385 - 2395
  • [7] Opioid Antagonist Naltrexone for the Treatment of Pathological Gambling in Parkinson Disease
    Bosco, Domenico
    Plastino, Massimiliano
    Colica, Carmela
    Bosco, Francesca
    Arianna, Spano
    Vecchio, Antonino
    Galati, Francesco
    Cristiano, Dario
    Consoli, Arturo
    Consoli, Domenico
    [J]. CLINICAL NEUROPHARMACOLOGY, 2012, 35 (03) : 118 - 120
  • [8] LOW PLATELET MONOAMINE-OXIDASE ACTIVITY IN PATHOLOGICAL GAMBLING
    CARRASCO, JL
    SAIZRUIZ, J
    HOLLANDER, E
    CESAR, J
    LOPEZIBOR, JJ
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1994, 90 (06) : 427 - 431
  • [9] Pyromania Associated with Escitalopram in a Child
    Ceylan, Mehmet Fatih
    Durukan, Ibrahim
    Turkbay, Tumer
    Akca, Omer Faruk
    Kara, Koray
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (04) : 381 - 382
  • [10] Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
    Cilia, Roberto
    Siri, Chiara
    Marotta, Giorgio
    Isaias, Ioannis U.
    De Gaspari, Danilo
    Canesi, Margherita
    Pezzoli, Gianni
    Antonini, Angelo
    [J]. ARCHIVES OF NEUROLOGY, 2008, 65 (12) : 1604 - 1611